Not so different from me… the startup that paid for the floor on which I stand emerged from a place whose name may be translated as "medical/technical research something", located between a hospital and a university. While that startup received no subsidies directly, I don't mind admitting that the subsidies that went into that area (from several parts of the state) were key to starting up.
Moderna struck it rich. Most of the companies that are founded on the fringes of hospitals and universities don't, they may lead to someone owning a nice flat, if even that.
If you want to block the occasional startup from striking it rich, you either have to improve the deal in another way or accept that the innovation decreases. For example, if you were to pay all of the research instead of most, you might be able to get all of the proceeds from the successes and keep the innovation going. As I understand it, that's a big "if" because the countries that have tried it haven't been very good at picking the right research to fund.
